Meeting
2023 ASCO Annual Meeting
The study of immune-related adverse events in a community-based centre.
Authors
Sandhya Cautha
Bronxcare Health System, Bronx, NY
Sandhya Cautha , Kevin R. Jain , Pravash Budhathoki , Tobechukwu Joseph Okobi , Tanushree Bhatt , Valentina Moirangthem , Sorab Gupta , Thanh-Ha T. Luong , Ahmad Hanif
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Other IO-Related Topics
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 2642)
DOI
10.1200/JCO.2023.41.16_suppl.2642
Abstract #
2642
Poster Bd #
484
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Predictive biomarkers for response to immunotherapy in patients with deficient DNA mismatch repair metastatic colorectal cancer.
First Author: Amos Stemmer
Poster
2022 ASCO Annual Meeting
The effect of the microbiome on immune checkpoint inhibitor toxicity in patients with melanoma.
First Author: Nyelia Williams
Poster
2022 ASCO Annual Meeting
A retrospective study of ipilimumab plus nivolumab in anti–PD-L1/PD-1-refractory merkel cell carcinoma.
First Author: Sophia Z. Shalhout
Poster
2024 ASCO Genitourinary Cancers Symposium
Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immunotherapy: A systematic review and meta-analysis.
First Author: Fengnian Zhao